Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia – a multicentre trial SAKK 32/95-Reference-Cited by-同舟云学术

Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia – a multicentre trial SAKK 32/95

Published:2009-01 Issue:1 Volume:50 Page:133-136
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Zenhäusern Reinhard,Von Rohr Albert,Rufibach Kaspar,Solenthaler Max,Meyer-Monard Sandrine,Gratwohl Alois,Hess Urs,Bargetzi Mario J.,Kovacsovic Tibor,Leoncini Leda,Tobler Andreas,for the Swiss Group for Clinical Ca

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190802527681

Reference15 articles.

1. HAIRY-CELL LEUKAEMIA: BIOLOGY AND MANAGEMENT

2. Advances in the treatment of hairy-cell leukaemia

3. A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia

4. Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL‐V);British Journal of Haematology;2020-10-14

2. Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial;Blood Advances;2020-08-10

3. Response to the Therapy in Hairy Cell Leukemia: Systematic Review and Meta-Analysis;Clinical Lymphoma Myeloma and Leukemia;2018-06

4. Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2017-11

5. Historical overview of hairy cell leukemia;Best Practice & Research Clinical Haematology;2015-12